DHR · News · 20261104N

Rapid Infection Diagnostic Assay

DANAHER CORP /DE/ · 2026-11-04 · Importance 34 · Surprise 42

Beckman Coulter Diagnostics received FDA clearance for the Access MeMed BV assay, which distinguishes bacterial from viral infections in about 15 minutes. The test fits into existing laboratory workflows and is intended to support antimicrobial stewardship by helping clinicians curb unnecessary antibiotic use. It can also add consumables use on Danaher’s installed analyzer base.

Key facts

• The FDA cleared Beckman Coulter Diagnostics' Access MeMed BV rapid assay, which distinguishes bacterial from viral infections in about 15 minutes and fits into existing lab workflows. source